TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
H.C. Wainwright Resumes TG Therapeutics (TGTX) at Buy
August 12, 2015 7:24 AM EDTH.C. Wainwright resumed coverage on TG Therapeutics (NASDAQ: TGTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on TG Therapeutics click here. For more ratings news on TG Therapeutics click here.
Shares of TG Therapeutics closed at $16.11 yesterday.
... MoreTG Therapeutics (TGTX) Misses Q2 EPS by 8c
August 10, 2015 9:14 AM EDTTG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
... More